What time is it in Sana (Yemen) ?
Local news
-
09/09/26 [Morningstar%2c Inc.] > Sana Biotechnology Inc Ordinary Shares SANA : Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
-
27/04/26 [Yahoo Finance] > Sana Biotech (SANA), Mayo Clinic Partner to Advance Cell Therapy for Type 1 Diabetes : The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
-
23/04/26 [Yahoo Finance] > Assessing Sana Biotechnology (SANA) Valuation After Mayo Clinic Partnership And Equity Investment : The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
-
19/01/26 [Seeking Alpha] > Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips : SANA’s thesis rests on hypoimmune islet replacement for T1D. UP421 gives it early human validation, and SC451 is the main scalable follow-on asset. SC451’s planned 2026 IND is the primary catalyst ...
-
16/10/25 [Seeking Alpha] > Sana Biotechnology: A Big Winner In Waiting? Maybe, But It Won't Happen Overnight : Sana Biotechnology, Inc. surged after hedge fund manager Eric Jackson called it a potential "100-bagger" due to its pioneering diabetes cell therapy. Sana Biotechnology's breakthrough islet cell ...
-
16/09/25 [Wall Street Journal] > Workday to Buy Sana for $1.1 Billion as Part of Enterprise AI Push : Workday WDAY1.48%increase; up pointing triangle is acquiring Sana, an AI company focused on workplace tools, for $1.1 billion as part of a broader push to offer companies and their employees AI ...
-
08/01/25 [FierceBiotech] > Sana’s cell therapy may be ‘transformative cure’ for type 1 diabetes: analysts : Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with type 1 diabetes, sending the company’s share price up by about 200%. The data ...
-
05/11/24 [FierceBiotech] > Sana strips back cancer, CNS programs as cell therapy biotech warns of further layoffs : Sana Biotechnology has become the latest cell therapy biotech to shift resources from cancer to autoimmune diseases as part of a strategic refocus that sounds likely to include a side order of layoffs ...
-
17/12/21 [Soompi] > Sana Shares Her Future Hopes For TWICE, Why Her Members Are So Precious To Her, And More : TWICE’s Sana has participated in a photo shoot with Cosmopolitan Korea! In 2021, TWICE had numerous music releases that were met with much global success, including their third studio album “Formula ...
-
04/02/21 [GeekWire] > Sana joins Nasdaq with blockbuster $587M IPO : Chronicling the Seattle and Pacific Northwest startup scene. SEE MORE by John Cook on Feb 4, 2021 at 7:27 am May 23, 2021 at 7:59 am Sana’s gene editing tech could provide treatments for a number of ...